Does ORITAVANCIN DIPHOSPHATE Cause Incorrect product administration duration? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Incorrect product administration duration have been filed in association with ORITAVANCIN DIPHOSPHATE (Kimyrsa). This represents 2.5% of all adverse event reports for ORITAVANCIN DIPHOSPHATE.
7
Reports of Incorrect product administration duration with ORITAVANCIN DIPHOSPHATE
2.5%
of all ORITAVANCIN DIPHOSPHATE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Incorrect product administration duration From ORITAVANCIN DIPHOSPHATE?
Of the 7 reports.
Is Incorrect product administration duration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ORITAVANCIN DIPHOSPHATE. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does ORITAVANCIN DIPHOSPHATE Cause?
Multiple use of single-use product (102)
Chills (87)
Infusion related reaction (63)
Off label use (49)
Back pain (41)
Pruritus (36)
Dyspnoea (35)
Flushing (35)
Tremor (35)
Nausea (33)
What Other Drugs Cause Incorrect product administration duration?
ETONOGESTREL (3,974)
POLYETHYLENE GLYCOL 3350 (2,129)
NIRMATRELVIR\RITONAVIR (744)
DOCOSANOL (634)
LANSOPRAZOLE (564)
LOPERAMIDE (543)
NAPROXEN (499)
INSULIN LISPRO (479)
DICLOFENAC (362)
OMEPRAZOLE (302)
Which ORITAVANCIN DIPHOSPHATE Alternatives Have Lower Incorrect product administration duration Risk?
ORITAVANCIN DIPHOSPHATE vs ORLISTAT
ORITAVANCIN DIPHOSPHATE vs ORNIDAZOLE
ORITAVANCIN DIPHOSPHATE vs ORPHENADRINE
ORITAVANCIN DIPHOSPHATE vs OSELTAMIVIR
ORITAVANCIN DIPHOSPHATE vs OSILODROSTAT